Again with all due respect the statement "whatever the raising there's going to be dilution" is simply not an accurate statement IMHO.
Renouceable Rights issues do NOT dilute existing holders.
Equal rights are offered to all based on the exisiting holding.
The shareholder either takes up their rights (in which case they are NOT diluted.. they simply maintain their existing % stake in the company) or they renounce them and are paid by another for the "rights", and thereby receive compensation for not participating (and their dilution)
The key issue here is it's the shareholder who decides whether they maintain their equal stake in the company (and it's future prosperity) NOT some other third party (like an outsider)
Why is it that in 2016, it is not understood why RR's are the preferable and fairest way to raise capital for shareholders?
- Forums
- ASX - By Stock
- AVR
- Cost Saving Strategy
Cost Saving Strategy, page-34
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online